These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China. Jia C; Zhao D; Li Y; Gao Y; Zhang X; Li X; Lv S; Li R; Zhu X; Liu S Clin Chim Acta; 2023 Jan; 539():90-96. PubMed ID: 36516925 [TBL] [Abstract][Full Text] [Related]
6. Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy. Gruber D; Lloyd-Puryear M; Armstrong N; Scavina M; Tavakoli NP; Brower AM; Caggana M; Chung WK Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):197-205. PubMed ID: 36152336 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy. Moat SJ; Korpimäki T; Furu P; Hakala H; Polari H; Meriö L; Mäkinen P; Weeks I Clin Chem; 2017 Apr; 63(4):908-914. PubMed ID: 28209627 [TBL] [Abstract][Full Text] [Related]
8. Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina. Kucera KS; Boyea BL; Migliore B; Potter SN; Robles VR; Kutsa O; Cope H; Okoniewski KC; Wheeler A; Rehder CW; Smith EC; Peay HL Genet Med; 2024 Jan; 26(1):101009. PubMed ID: 37864479 [TBL] [Abstract][Full Text] [Related]
9. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. Drousiotou A; Ioannou P; Georgiou T; Mavrikiou E; Christopoulos G; Kyriakides T; Voyasianos M; Argyriou A; Middleton L Genet Test; 1998; 2(1):55-60. PubMed ID: 10464597 [TBL] [Abstract][Full Text] [Related]
10. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Moat SJ; Bradley DM; Salmon R; Clarke A; Hartley L Eur J Hum Genet; 2013 Oct; 21(10):1049-53. PubMed ID: 23340516 [TBL] [Abstract][Full Text] [Related]
11. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy. Mendell JR; Lloyd-Puryear M Muscle Nerve; 2013 Jul; 48(1):21-6. PubMed ID: 23716304 [TBL] [Abstract][Full Text] [Related]
12. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study. Tavakoli NP; Gruber D; Armstrong N; Chung WK; Maloney B; Park S; Wynn J; Koval-Burt C; Verdade L; Tegay DH; Cohen LL; Shapiro N; Kennedy A; Noritz G; Ciafaloni E; Weinberger B; Ellington M; Schleien C; Spinazzola R; Sood S; Brower A; Lloyd-Puryear M; Caggana M; Ann Clin Transl Neurol; 2023 Aug; 10(8):1383-1396. PubMed ID: 37350320 [TBL] [Abstract][Full Text] [Related]
13. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction. Greenberg CR; Jacobs HK; Halliday W; Wrogemann K Am J Med Genet; 1991 Apr; 39(1):68-75. PubMed ID: 1867267 [TBL] [Abstract][Full Text] [Related]
14. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup. Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761 [TBL] [Abstract][Full Text] [Related]
15. Duchenne muscular dystrophy: issues in expanding newborn screening. Kemper AR; Wake MA Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277 [TBL] [Abstract][Full Text] [Related]
17. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Mendell JR; Shilling C; Leslie ND; Flanigan KM; al-Dahhak R; Gastier-Foster J; Kneile K; Dunn DM; Duval B; Aoyagi A; Hamil C; Mahmoud M; Roush K; Bird L; Rankin C; Lilly H; Street N; Chandrasekar R; Weiss RB Ann Neurol; 2012 Mar; 71(3):304-13. PubMed ID: 22451200 [TBL] [Abstract][Full Text] [Related]
18. [Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types]. Breucking E; Reimnitz P; Schara U; Mortier W Anaesthesist; 2000 Mar; 49(3):187-95. PubMed ID: 10788987 [TBL] [Abstract][Full Text] [Related]
19. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Hauser E; Toifl K; Mad A; Bittner R Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369 [TBL] [Abstract][Full Text] [Related]
20. Giovanni Nigro and the Naples's school: historical contribution to the knowledge of heart involvement in Duchenne/Becker muscular dystrophies. Politano L Acta Myol; 2020 Dec; 39(4):187-190. PubMed ID: 33458573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]